≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_OVARY_SEROUS_EXALLC for full statistics.

Serous carcinoma of ovary

Endpoint Browser

C3_OVARY_SEROUS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C56.71&
  • Cause of death: ICD-10 — C56.71&
  • Cancer registry: Topography ICD-O-3 — C56
  • Cancer registry: Morphology ICD-O-3 — 8441
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

1191

4. Check minimum number of events

None

1191

5. Include endpoints

None

1191

6. Filter based on genotype QC (FinnGen only)

1191

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF9

Similar endpoints

↥

List of similar endpoints to Serous carcinoma of ovary based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1191 1191 -
Unadjusted period prevalence (%) 0.41 0.41 -
Median age at first event (years) 64.68 64.68 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1068
Matched controls
10679
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A03FA01
ATC
metoclopramide; systemic, rectal
14.7
323.0
791
1736
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
234.2
323.0
398
27
128
Kela drug reimbursment
Cancers of female genital organs
240.7
323.0
746
101
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
323.0
1020
*
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
3277.5
323.0
391
*
JAL30
NOMESCO Finland
Omentectomy
139.4
323.0
448
55
H02AB02
ATC
dexamethasone; systemic
18.2
323.0
622
761
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
153.4
322.5
330
31
A04AA01
ATC
ondansetron; systemic, rectal
20.5
308.2
502
442
C56
ICD-10 Finland
Malignant neoplasm of ovary
289.0
300.6
294
14
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
32.7
252.9
340
150
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
+∞
250.1
230
*
JEA00
NOMESCO Finland
Appendectomy
19.4
236.8
383
299
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
17.9
217.0
361
296
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
24.2
212.0
312
179
B01AB10
ATC
tinzaparin; parenteral
13.3
199.7
383
429
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
18.8
188.0
303
220
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
18.4
184.5
300
222
WX302
NOMESCO Finland
Thoracal epidural anesthesy
16.3
183.7
315
267
R18
ICD-10 Finland
Ascites
41.3
181.9
229
70
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
21.1
180.9
278
175
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
13.8
177.9
331
337
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
11.8
162.3
326
382
L03AA13
ATC
pegfilgrastim; parenteral
14.4
156.5
282
260
JN4BD
NOMESCO Finland
Extensive body CT
8.2
154.0
401
732
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
48.5
135.7
165
40
JAL00
NOMESCO Finland
Biopsy of peritoneum
73.3
128.8
146
23
Z51.5
ICD-10 Finland
Palliative care
10.5
117.0
245
294
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
126.2
115.8
123
11
LCD00
NOMESCO Finland
Hysterectomy
8.3
114.2
279
435
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
6.3
110.4
341
739
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.3
107.5
608
2509
L03AA14
ATC
lipegfilgrastim; parenteral
18.5
107.1
170
108
JAH01
NOMESCO Finland
Laparoscopy
11.0
105.8
214
237
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
86.8
104.6
116
15
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
548.1
102.4
100
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
18.2
101.5
162
104
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
35.1
99.8
130
42
B01AB05
ATC
enoxaparin; parenteral
4.0
96.7
609
2676
A04AA55
ATC
palonosetron, combinations; systemic
12.4
96.3
182
174
ZX120
NOMESCO Finland
Intravenous
6.2
90.4
274
562
WW500
NOMESCO Finland
Blood transfusion
11.5
90.4
177
181
8460/3-C56.9
ICD-O-3
Low grade serous carcinoma of ovary
+∞
88.8
84
*
X77
ICPC
Malignant neopl genital female other
94.7
86.6
95
11
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
22.2
85.1
126
64
JN4AD
NOMESCO Finland
Body CT examination
6.6
84.6
242
456
N02AA05
ATC
oxycodone; systemic
4.7
82.9
335
944
L03AA02
ATC
filgrastim; parenteral
13.0
82.0
150
132
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
77.2
81.7
92
13
3009
Kela drug reimbursment
Niraparib
292.5
80.7
81
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
39.7
79.9
101
28
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
24.4
79.5
114
52
JAH00
NOMESCO Finland
Laparotomy
15.5
78.2
132
96
1510
Kela drug reimbursment
Niraparib
280.3
77.5
78
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
92.3
77.2
85
10
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
30.7
76.7
103
37
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
16.4
74.1
122
83
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
73.8
72.4
82
12
TPH07
NOMESCO Finland
Cathetrisation of artery
5.2
72.3
253
600
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
136.2
71.9
76
6
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
53.5
70.5
84
17
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
48.6
63.6
77
17
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
20.5
62.2
94
50
L01XK02
ATC
niraparib; oral
222.9
61.8
63
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
59.5
524
2618
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
43.5
59.0
73
18
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
8.5
59.0
135
178
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.2
56.3
245
708
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
15.3
55.3
93
66
8461/3-C57.0
ICD-O-3
High grade serous carcinoma of fallopian tube
72.9
54.8
62
9
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.4
52.9
113
132
1XC07
NOMESCO Finland
NA
68.0
50.7
58
9
JMA10
NOMESCO Finland
Transabdominal total splenectomy
52.8
50.4
60
12
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.2
49.9
127
196
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
8.7
49.6
111
140
A04AA03
ATC
tropisetron; systemic
40.3
48.7
61
16
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
37.3
47.1
60
17
JBA10
NOMESCO Finland
Transabdominal biopsy or excision of lesion of diaphragm
466.8
45.6
45
*
L02BG04
ATC
letrozole; oral
4.0
45.4
202
586
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
17.7
44.3
70
42
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
122.8
44.1
47
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.2
44.1
146
314
A04AA02
ATC
granisetron; systemic, transdermal
4.5
43.5
167
420
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
24.8
43.2
61
26
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
9.2
41.8
90
106
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
62.7
41.6
48
8
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
25.0
40.5
57
24
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
46.6
40.4
49
11
TJA10
NOMESCO Finland
Laparocentesis
38.2
40.3
51
14
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
50.1
40.1
48
10
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
89.6
39.1
43
5
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
39.4
39.1
49
13
JFB46
NOMESCO Finland
Resection of sigmoid colon
13.4
38.0
67
53
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
8.6
36.1
80
99
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
5.3
35.6
115
239
Z31.5
ICD-10 Finland
Genetic counselling
5.3
34.9
113
235
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
40.7
34.6
43
11
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
8.9
34.4
75
90
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
21.8
34.2
50
24
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.9
33.5
231
919
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
42.6
33.3
41
10
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
76.7
33.0
37
5
ZXC40
NOMESCO Finland
Use of ultrasound
18.4
33.0
51
29
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
46.1
33.0
40
9
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
9.8
32.2
66
71
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
30.9
324
1630
JN3AD
NOMESCO Finland
Abdominal CT examination
3.6
30.3
146
445
389
Kela drug reimbursment
Olaparib
70.0
30.0
34
5
1511
Kela drug reimbursment
Olaparib
70.0
30.0
34
5
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
29.2
203
804
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.9
28.9
201
794
L01XX54
ATC
[U] niraparib; oral
+∞
28.2
27
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
8.4
28.2
63
79
J94.8
ICD-10 Finland
Other specified pleural conditions
11.8
28.1
52
46
WF049
NOMESCO Finland
Radiotherapy of metastasis
6.2
27.7
77
133
JFF10
NOMESCO Finland
Loop enterostomy
20.7
27.1
40
20
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
20.2
26.2
39
20
JFB00
NOMESCO Finland
Partial resection of small intestine
9.1
26.0
55
63
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
5.7
26.0
77
144
C56.74
ICD-10 Finland
Mesonephroid epithelial carcinoma of the ovary
74.6
25.9
29
*
1XA02
NOMESCO Finland
NA
266.7
25.8
26
*
C574, 8461, 3
ICD-O-3
NA
138.3
25.7
27
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.6
25.5
93
219
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
12.7
24.7
44
36
JAL31
NOMESCO Finland
Laparoscopic omentectomy
25.0
24.5
34
14
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
9.7
24.5
50
54
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
12.8
24.2
43
35
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
88.8
23.7
26
*
L01XK01
ATC
olaparib; oral
88.8
23.7
26
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
7.8
23.6
55
74
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
10.6
22.7
44
43
D70.82
ICD-10 Finland
Drug-induced neutropenia
6.9
22.7
57
86
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
22.0
439
2828
WX402
NOMESCO Finland
General anaesthesia
2.3
22.0
228
1113
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
21.9
527
3631
A98
ICPC
Health maint/preventive medicine
0.4
21.6
877
9820
R50.9
ICD-10 Finland
Fever, unspecified
2.6
21.4
174
746
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
7.1
21.2
52
76
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
28.7
21.0
28
10
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
14.4
20.9
35
25
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
6.6
20.7
54
86
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
6.7
20.6
53
83
8310/3-C56.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of ovary
58.7
20.0
23
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.8
19.8
88
249
JFB53
NOMESCO Finland
Resection of sigmoid colon with partial proctectomy
74.9
19.7
22
*
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
18.1
19.6
30
17
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
19.1
184
861
8102
FHL
Second look"" surgery for a malignant tumor
101.8
18.6
20
*
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
25.5
18.3
25
10
JFA70
NOMESCO Finland
Suture of small intestine
27.2
17.9
24
9
KCH00
NOMESCO Finland
Suture of bladder
23.2
17.8
25
11
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
10.0
17.7
35
36
C567
ICD-10 Finland
NA
96.7
17.6
19
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.2
17.5
67
166
XX1XW
NOMESCO Finland
Extensive written report from radiologist
5.9
17.2
48
84
D69.5
ICD-10 Finland
Secondary thrombocytopenia
35.6
16.7
21
6
R11
ICD-10 Finland
Nausea and vomiting
2.6
16.7
129
535
ZX121
NOMESCO Finland
Central venous catheter
28.0
16.5
22
8
JJA40
NOMESCO Finland
Excision of lesion of liver
172.6
16.5
17
*
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
11.0
16.5
31
29
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
23.5
16.5
23
10
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.2
16.3
89
297
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
16.0
125
519
JAW96
NOMESCO Finland
Other operation on abdominal wall, peritoneum, mesentery or omentum
24.9
16.0
22
9
L01XX46
ATC
[U] olaparib; oral
60.9
15.8
18
*
JBA00
NOMESCO Finland
Transabdominal repair of diaphragm for rupture
+∞
15.7
15
*
K56.7
ICD-10 Finland
Ileus, unspecified
6.2
15.4
41
68
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
15.3
132
579
B03XA02
ATC
darbepoetin alfa; parenteral
6.1
15.2
41
69
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
23.8
15.1
21
9
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.0
14.6
88
312
A79
ICPC
Malignancy NOS
6.3
14.5
38
62
JBA20
NOMESCO Finland
Transabdominal partial excision of diaphragm
152.0
14.5
15
*
JFA80
NOMESCO Finland
Suture of colon
36.6
14.5
18
5
C56.91
ICD-10 Finland
Malignant granulosa cell tumor in ovary
36.6
14.5
18
5
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
43.1
14.1
17
*
A02BC02
ATC
pantoprazole; systemic
1.7
14.0
754
6253
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
14.0
159
796
JN4CD
NOMESCO Finland
Very extensive body CT
3.5
13.7
65
195
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
4.7
13.7
46
101
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
16.5
13.5
21
13
L01CB01
ATC
etoposide; systemic
13.0
13.4
23
18
N02AX02
ATC
tramadol; systemic, rectal
1.6
13.4
476
3508
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
7.7
13.2
30
40
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
12.3
13.1
23
19
WZC30
NOMESCO Finland
Teaching
2.1
13.1
167
877
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
5.5
13.1
38
71
A06AH03
ATC
naloxegol; oral
8.9
13.0
27
31
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.3
13.0
48
116
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
22.8
12.9
18
8
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
4.7
12.8
43
95
X81
ICPC
Genital neopl female other/unspecif
24.6
12.5
17
7
WC401
NOMESCO Finland
Simple antibody therapy of local recurrence of tumour                  
131.5
12.5
13
*
LAF17
NOMESCO Finland
Laparoscopic excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
131.5
12.5
13
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.4
12.4
60
184
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
6.3
12.3
32
52
JFB20
NOMESCO Finland
Ileocaecal resection
10.7
12.3
23
22
KBV10
NOMESCO Finland
Removal of stent from ureter
9.8
12.3
24
25
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
18.3
12.1
18
10
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
12.0
106
472
TJF80
NOMESCO Finland
Ostomy education
7.8
11.7
26
34
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
7.8
11.7
26
34
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
65.7
11.6
13
*
JAL96
NOMESCO Finland
Other excision of lesion of peritoneum
23.2
11.6
16
7
8010/3-C56.9
ICD-O-3
Carcinoma, NOS, of ovary
+∞
11.5
11
*
C76.3
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Pelvis
+∞
11.5
11
*
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
6.7
11.3
28
43
3AA13
NOMESCO Finland
NA
17.3
11.2
17
10
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
12.9
11.2
19
15
LEB00
NOMESCO Finland
Biopsy of vagina
4.0
11.1
43
110
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
43.8
10.9
13
*
JN3DM
NOMESCO Finland
Abdominal very extensive MRI examination with 3 Tesla magnet
43.8
10.9
13
*
XX3DW
NOMESCO Finland
Time consuming IT work
2.1
10.9
129
656
JFF30
NOMESCO Finland
Other colostomy
21.7
10.7
15
7
K56.0
ICD-10 Finland
Paralytic ileus
9.3
10.5
21
23
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
10.2
10.5
20
20
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
5.3
10.5
31
60
GAE03
NOMESCO Finland
Suture of chest wall
+∞
10.4
10
*
C48.19
ICD-10 Finland
Malignant tumor in specified location in peritoneum other or unspecified histlogy
+∞
10.4
10
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.2
10.4
38
92
L02BA01
ATC
tamoxifen; oral
2.5
10.4
82
343
C48.20
ICD-10 Finland
Malignant tumor in unspecified localization in the peritoneum without histology
32.9
10.3
13
*
JFB30
NOMESCO Finland
Right hemicolectomy
5.3
10.2
30
58
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
4.7
10.1
33
72
JFB40
NOMESCO Finland
Resection of transverse colon
26.3
9.8
13
5
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.8
9.8
62
230
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
5.9
9.7
26
45
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
13.5
9.7
16
12
TLE30
NOMESCO Finland
Tamponation of vagina
13.5
9.7
16
12
GAE06
NOMESCO Finland
Excision of lesion of chest wall
55.5
9.7
11
*
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
9.2
9.5
19
21
8980/3-C56.9
ICD-O-3
Carcinosarcoma, NOS, of ovary
100.9
9.4
10
*
8140/3-C56.9
ICD-O-3
Adenocarcinoma, NOS, of ovary
100.9
9.4
10
*
1DB01
NOMESCO Finland
NA
100.9
9.4
10
*
JFF13
NOMESCO Finland
Terminal enterostomy
30.3
9.4
12
*
C579, 8461, 3
ICD-O-3
NA
+∞
9.4
9
*
8442/1-C56.9
ICD-O-3
Serous borderline tumor, NOS, of ovary
12.5
9.4
16
13
121
Kela drug reimbursment
Severe hypofunction of sexual glands
3.4
9.3
44
134
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
9.6
9.3
18
19
N02BE01
ATC
paracetamol; systemic, rectal
1.8
9.2
946
8676
R4190
NOMESCO Finland
Nutritional therapy
3.4
9.2
44
135
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
9.1
38
105
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.5
9.1
41
121
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
7.1
9.0
21
30
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
15.7
9.0
14
9
RS220
NOMESCO Finland
NA
5.5
8.9
25
46
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
12.7
8.9
15
12
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
50.4
8.7
10
*
A04AD12
ATC
aprepitant; systemic
3.4
8.6
40
121
SPAT1153
SPAT
Removal of sutures
1.5
8.5
367
2748
JFB43
NOMESCO Finland
Left hemicolectomy
9.1
8.5
17
19
LWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gynaecological surgery
27.7
8.5
11
*
XW2AT
NOMESCO Finland
Cytology of deep organ with ultrasound quidance
27.7
8.5
11
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
20.2
8.5
12
6
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
90.7
8.4
9
*
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
12.9
8.4
14
11
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
6.8
8.4
20
30
ZX100
NOMESCO Finland
Oral
5.3
8.3
24
46
JFF23
NOMESCO Finland
Transversostomy
5.9
8.3
22
38
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
5.9
8.3
22
38
L15
ICPC
Knee symptom/complaint
0.6
8.3
119
1916
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
17.3
8.1
12
7
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
17.3
8.1
12
7
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
10.1
8.0
15
15
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
7.9
93
473
TGA30
NOMESCO Finland
Thoracocentesis
9.5
7.8
15
16
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
9.5
7.8
15
16
8205
FHL
Subradical ovarian malignancy removal (includes possible genital and omet removal)
45.3
7.7
9
*
D48.49
ICD-10 Finland
Tumor of uncertain or unknown nature in the peritoneum, of unknown origin
45.3
7.7
9
*
1CD01
NOMESCO Finland
NA
18.5
7.6
11
6
JJB10
NOMESCO Finland
Atypcal resection of liver
18.5
7.6
11
6
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
5.8
7.5
20
35
M01AH05
ATC
etoricoxib; oral
0.7
7.5
438
5329
G03AC03
ATC
levonorgestrel; systemic
0.5
7.4
56
1084
HA1AA
NOMESCO Finland
X-ray mammography
1.8
7.4
134
797
SPAT1125
SPAT
Stoma care and guidance
4.1
7.4
27
67
WX892
NOMESCO Finland
Monitored bed care
2.1
7.4
79
388
XX1VW
NOMESCO Finland
Written report from radiologist
8.4
7.3
15
18
WX320
NOMESCO Finland
Spinalanesthesy
0.6
7.3
113
1792
8480/3-C56.9
ICD-O-3
Mucinous adenocarcinoma of ovary
+∞
7.3
7
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
5.5
7.2
20
37
C10AA07
ATC
rosuvastatin; oral
0.6
7.2
133
2024
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
30.2
7.2
9
*
Z93.3
ICD-10 Finland
Colostomy status
6.6
7.1
17
26
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
7.1
275
1999
WF004
NOMESCO Finland
Palliative radiotherapy
3.8
7.1
28
75
Z93.2
ICD-10 Finland
Ileostomy status
8.8
7.1
14
16
S18
ICPC
Laceration/cut
1.4
7.0
441
3530
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
4.3
6.9
24
57
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
5.9
6.9
18
31
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.6
6.8
172
2448
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
11.0
6.8
12
11
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
5.7
6.8
18
32
JFC20
NOMESCO Finland
Other enterocolostomy
40.3
6.8
8
*
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
16.8
6.7
10
6
R42
ICD-10 Finland
Dizziness and giddiness
0.6
6.7
124
1890
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
22.7
6.7
9
*
JGA60
NOMESCO Finland
Suture of rectum
22.7
6.7
9
*
Z51.88
ICD-10 Finland
Other specified medical care
3.4
6.6
30
91
N05CF01
ATC
zopiclone; oral
1.4
6.5
363
2832
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
6.5
221
1556
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.7
6.5
26
71
M54.5
ICD-10 Finland
Low back pain
0.7
6.5
193
2663
A06AD11
ATC
lactulose; oral
1.6
6.4
154
995
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
8.2
6.3
13
16
JFB50
NOMESCO Finland
Other resection of colon
9.3
6.3
12
13
C48.10
ICD-10 Finland
Malignant tumor in specified location in the peritoneum without histology
+∞
6.3
6
*
WB313
NOMESCO Finland
Adjuvant multiple therapy of malignancy with biomodifiers
+∞
6.3
6
*
WC402
NOMESCO Finland
Demanding antibody therapy of local recurrence of tumour       
+∞
6.3
6
*
8441/2-C57.0
ICD-O-3
Serous intraepithelial carcinoma of fallopian tube
+∞
6.3
6
*
LAF01
NOMESCO Finland
Laparoscopic unilateral salpingo-oophorectomy
2.8
6.2
38
141
T80.2
ICD-10 Finland
Infections following infusion, transfusion and therapeutic injection
26.8
6.2
8
*
JFC00
NOMESCO Finland
Entero-enterostomy
26.8
6.2
8
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.1
6.2
22
54
JKA20
NOMESCO Finland
Cholecystectomy
3.2
6.2
30
96
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
0.5
6.2
54
997
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
2.2
6.2
56
257
SAA02
NOMESCO Finland
Basic examination of mouth
0.7
6.1
450
5350
R05
ICPC
Cough
0.6
6.1
121
1820
R74
ICPC
Upper respiratory infection acute
0.6
6.1
135
1978
Z01.2
ICD-10 Finland
Dental examination
0.7
6.1
257
3336
D99
ICPC
Disease digestive system other
4.4
6.1
20
46
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
6.0
36
132
D27.99
ICD-10 Finland
Benign tumor of the ovary (ovary), unspecified histology
5.2
6.0
17
33
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
2.5
6.0
44
182

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
900
875
39.00
307.65
19.9
3.0
u/ml
166.1
61.9
5.61
888
841
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
492
368
22.08
307.65
2.0
1.4
pmol/l
619.2
233.5
5.66
469
362
(4281824)
340
172
27.27
307.65
1.3
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
524
1250
6.70
226.38
1.9
4.0
ug/l
3.9
13.9
2.67
380
1004
(4035726)
384
1066
4.84
130.55
1.5
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
471
1724
3.87
107.01
7.1
3.0
mmol/l
0.8
0.8
9.18
460
1579
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
103
98
11.41
95.60
1.1
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
825
4849
3.28
79.21
7.0
4.2
g/l
32.0
35.4
40.52
807
4482
(3023368) Bacteria identified in Blood by Culture
547
2640
2.98
73.19
4.0
3.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
642
3398
2.93
72.07
3.3
2.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
83
87
10.18
71.74
1.3
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
805
4916
2.97
67.29
5.6
3.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
529
2597
2.87
67.24
3.3
2.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
311
1163
3.27
63.90
6.4
6.2
mmol/l
0.7
1.3
2.54
271
932
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
877
5712
3.03
63.10
11.3
5.8
umol/l
8.5
10.5
5.51
857
5381
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
164
406
4.52
61.43
1.9
3.1
u/ml
98.2
677.6
1.02
135
357
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
307
1164
3.21
61.38
6.4
6.2
kpa
5.1
5.1
0.24
300
1109
(3027801) Oxygen [Partial pressure] in Arterial blood
307
1164
3.21
61.38
6.4
6.2
kpa
16.9
12.6
19.72
300
1105
(3023487) Leukocytes [#/volume] in Peritoneal fluid
53
38
14.55
58.18
1.1
2.3
e6/l
4339.4
588.4
0.66
34
28
(3013650) Neutrophils [#/volume] in Blood by Automated count
912
6205
3.01
57.85
27.3
8.9
e9/l
3.5
4.0
11.47
825
5394
(3002173) Hemoglobin [Mass/volume] in Arterial blood
263
949
3.27
56.73
6.6
6.8
g/l
111.7
118.4
8.61
258
919
(3043409) Potassium [Moles/volume] in Arterial blood
135
312
4.75
54.91
5.7
3.5
mmol/l
3.8
3.8
0.31
130
290
(3008152) Bicarbonate [Moles/volume] in Arterial blood
196
610
3.65
53.18
8.9
6.2
mmol/l
24.5
24.9
0.67
191
568
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
757
9761
0.38
51.30
5.0
6.0
mmol/mol
39.9
39.8
0.07
677
8904
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
47
35
13.94
50.44
1.1
2.4
e6/l
8970.6
54345.3
0.41
22
20
(3018405) Lactate [Moles/volume] in Arterial blood
140
359
4.29
49.78
5.6
3.3
mmol/l
1.4
1.3
0.12
140
354
(3019060) Gas panel - Arterial blood
196
648
3.42
48.21
5.5
4.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
238
910
3.02
45.72
7.0
2.7
g/l
64.3
66.7
5.04
229
814
(3044007) Cell count panel - Peritoneal fluid
42
31
14.01
45.25
1.2
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
877
10502
0.37
44.53
4.2
5.3
mmol/l
2.9
2.8
3.03
769
9519
(3020891) Body temperature
143
405
3.88
44.23
6.4
4.0
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
36
22
16.84
42.82
3.1
2.7
ng/l
75.1
67.3
—
9
7
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
853
10266
0.40
39.88
3.8
4.7
mmol/l
4.9
4.8
1.85
749
9354
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
841
10180
0.41
39.86
3.8
4.7
mmol/l
1.6
1.6
1.06
738
9214
(3032080) INR in Blood by Coagulation assay
652
4219
2.21
38.61
7.0
8.8
inr
1.2
1.2
0.57
166
1175
(3023199) Leukocytes [#/volume] in Pleural fluid
65
106
6.43
38.53
1.2
1.3
e6/l
1783.8
1637.9
0.09
48
72
(3033799) Differential panel - Peritoneal fluid
40
36
11.46
38.15
1.2
1.8
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
107
275
4.18
37.71
1.7
2.5
%
210.6
190.1
1.83
107
263
(3028308) Erythrocytes [#/volume] in Pleural fluid
58
92
6.58
35.29
1.2
1.3
e6/l
24935.1
154578.2
0.83
34
50
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
95
235
4.31
35.18
1.6
3.2
u/ml
90.7
1504.4
0.70
87
215
(3016502) Oxygen saturation in Arterial blood
234
1013
2.63
34.81
6.8
6.5
%
97.5
95.7
3.97
229
977
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
235
1043
2.56
33.08
1.9
2.0
g/l
0.2
0.2
3.98
223
983
(3033658) Prothrombin time (PT) actual/Normal
452
2668
2.12
32.33
5.1
3.6
%
95.1
93.3
0.97
444
2588
(3014576) Chloride [Moles/volume] in Serum or Plasma
260
1246
2.39
30.79
8.1
5.8
mmol/l
104.3
104.0
0.35
254
1215
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
28
20
14.31
30.58
11.6
2.2
u/l
39.0
40.7
—
21
7
(40758558) Short blood count panel - Blood
464
2829
2.05
29.88
19.9
6.6
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
28
21
13.63
29.75
1.0
1.3
g/l
40.8
27.0
2.78
28
16
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
882
10270
0.46
28.46
4.8
4.9
mmol/l
5.9
5.9
0.37
785
9228
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
38
49
7.98
27.77
1.9
3.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
50
88
5.89
27.42
1.2
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
846
9971
0.48
27.24
5.6
5.6
mu/l
2.2
2.1
0.45
755
9032
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
823
9791
0.48
27.22
3.5
4.2
mmol/l
1.3
1.3
1.92
716
8774
(3003694) ABO and Rh group [Type] in Blood
417
2533
1.99
26.42
1.4
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
275
1431
2.20
26.38
1.7
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
512
3353
1.92
25.86
4.1
2.4
u/l
56.7
58.6
0.33
482
3041
(3000991) Gas panel - Venous blood
185
821
2.48
25.62
6.5
6.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
493
3256
1.88
23.70
8.1
2.9
u/l
36.1
32.9
0.21
478
3075
(3045788) Cell count panel - Pleural fluid
46
89
5.34
22.81
1.2
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
578
4046
1.83
22.79
3.5
3.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
156
3072
0.43
21.35
1.6
1.7
mmol/l
1.5
1.4
1.50
135
2564
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
715
8720
0.55
21.22
5.0
4.6
pmol/l
15.0
15.0
0.25
638
7873
(3009261) Glucose [Presence] in Urine by Test strip
708
5348
1.80
20.96
7.1
4.2
estimate
0.0
0.0
1.08
130
939
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
28
35
8.17
20.95
3.4
1.9
ug/l
11.3
2.5
—
9
22
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
33
50
6.76
20.92
1.2
1.1
u/l
10.0
11.7
0.62
33
43
(3021601) Nitrite [Presence] in Urine by Test strip
701
5313
1.78
20.17
10.1
5.6
estimate
0.0
0.0
0.50
124
938
(3035880) pH of Pleural fluid
31
46
6.89
20.03
1.1
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
774
6096
1.77
18.90
5.8
4.3
mmol/l
6.8
6.7
1.51
758
5701
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
86
302
2.99
18.66
2.6
3.5
u/ml
0.4
0.4
0.20
43
183
(3031040) Bacteria [#/volume] in Urine by Automated count
880
7268
1.81
17.47
6.5
5.2
e6/l
1520.9
3035.6
0.51
19
98
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
981
8398
1.95
17.16
12.5
7.4
u/l
90.5
78.6
5.40
952
7843
(40768804) Tissue Pathology biopsy report
617
4646
1.68
16.94
2.7
2.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
355
5053
0.58
16.36
2.2
2.3
nmol/l
77.8
81.1
1.41
322
4462
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
126
582
2.30
15.68
1.7
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
558
4165
1.64
15.30
6.0
3.4
mmol/l
2.4
2.4
2.41
526
3595
(3026692) Albumin [Mass/volume] in Peritoneal fluid
21
30
7.11
14.01
1.0
1.5
g/l
22.1
13.9
4.04
21
25
(3000963) Hemoglobin [Mass/volume] in Blood
1061
11269
0.46
13.77
49.9
21.9
g/l
120.1
131.2
129.17
1046
11087
(3010813) Leukocytes [#/volume] in Blood
1061
11268
0.47
13.71
49.5
21.8
e9/l
6.6
6.6
0.03
1034
10913
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
662
5236
1.60
13.71
5.8
5.3
mmol/l
1.2
1.2
31.14
626
4700
(3035941) MCH [Entitic mass]
1061
11267
0.47
13.66
49.3
21.7
pg
30.4
30.2
3.26
1046
11083
(3026361) Erythrocytes [#/volume] in Blood
1061
11267
0.47
13.66
49.5
21.8
e12/l
4.0
4.4
85.76
1036
10913
(3024731) MCV [Entitic volume]
1061
11265
0.47
13.55
49.4
21.7
fl
92.5
91.4
11.54
1046
11082
(3007461) Platelets [#/volume] in Blood
1061
11264
0.47
13.49
49.5
21.8
e9/l
274.1
260.0
6.56
1036
10953
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
225
1362
1.80
13.10
2.1
2.4
%
22.4
21.2
0.60
184
1151
(40761535) Cells panel - Urine sediment
164
900
1.95
12.96
5.3
3.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
145
775
1.99
12.34
1.5
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
372
2617
1.61
12.30
7.9
4.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
220
1355
1.76
12.00
10.4
23.9
inr
1.3
1.3
0.06
28
182
(3013707) Erythrocyte sedimentation rate by Westergren method
689
8107
0.64
11.99
3.5
4.4
mm/h
18.4
13.5
8.25
626
7443
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
17
23
7.48
11.86
1.2
1.1
ug/l
1643.4
187.6
—
8
15
(3004789) Transferrin [Mass/volume] in Serum or Plasma
232
1458
1.73
11.78
2.1
2.3
g/l
2.2
2.4
6.60
218
1341
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
261
1705
1.68
11.46
1.7
1.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
189
1136
1.79
11.16
2.9
2.4
umol/l
6.8
6.6
0.04
158
975
(3035350) Ketones [Presence] in Urine by Test strip
649
5255
1.52
11.06
7.5
4.2
estimate
0.0
0.0
0.00
123
948
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
695
5735
1.51
10.63
6.2
6.0
mmol/l
1.2
1.2
34.39
630
4824
(1761868) Lipid panel - Serum or Plasma
212
3177
0.60
10.49
2.8
3.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
65
272
2.47
10.10
1.4
1.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
241
1595
1.64
9.93
2.1
2.3
umol/l
13.6
12.4
0.93
231
1466
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
83
391
2.21
9.85
1.5
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
379
2811
1.51
9.43
7.0
4.6
estimate
0.0
0.0
0.80
127
943
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
117
640
1.92
9.28
1.5
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
478
3727
1.47
9.25
6.2
3.8
e6/l
100.9
108.6
0.07
325
2540
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
65
286
2.35
9.07
2.0
2.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
182
1145
1.70
9.06
1.6
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
848
7407
1.50
9.00
9.1
4.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
34
107
3.24
8.95
2.3
3.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
85
424
2.08
8.74
1.6
1.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
812
9059
0.67
8.66
30.7
16.2
%
35.6
38.4
14.69
542
6053
(3037121) Protein [Mass/volume] in Urine
74
354
2.16
8.48
8.5
3.0
g/l
0.1
0.3
4.51
43
110
(3002256) Pathology report gross observation
209
1403
1.59
8.00
1.2
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
37
133
2.84
7.80
1.6
1.7
u/l
28.1
1855.2
0.54
16
53
(3004809) Band form neutrophils/100 leukocytes in Blood
41
159
2.63
7.50
2.3
3.3
%
2.0
1.5
0.41
36
118
(3003458) Phosphate [Moles/volume] in Serum or Plasma
198
1348
1.56
7.09
4.3
4.4
mmol/l
1.0
1.0
0.51
184
1221
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1045
10979
0.61
6.85
23.9
11.1
u/l
22.8
23.3
0.53
1026
10536
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
379
4707
0.71
6.62
2.1
2.1
pmol/l
94.6
97.9
0.67
214
2141
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
66
334
2.03
6.58
1.9
2.2
ug/l
224.7
923.5
0.61
66
309
(3013727) Leukocytes other/100 leukocytes in Blood
14
29
4.87
6.46
2.1
4.8
%
52.7
55.5
0.14
14
29
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
207
1454
1.51
6.40
10.4
6.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
309
2365
1.41
6.09
1.8
1.8
mg/l
2.5
1.1
4.70
260
1824
(3017181) Myelocytes/100 leukocytes in Blood
140
912
1.61
6.03
3.1
3.9
%
1.4
0.9
1.22
75
229
(3019198) Lymphocytes [#/volume] in Blood
623
5355
1.34
5.85
7.6
5.7
e9/l
1.7
1.9
5.55
541
4657
(3002582) Erythrocytes [#/volume] in Urine
386
3089
1.37
5.78
3.2
3.2
e6/l
25.2
46.5
1.50
300
2320
(3002032) Base excess in Venous blood by calculation
139
917
1.58
5.68
3.4
3.0
mmol/l
2.8
2.1
1.18
116
758
(3019069) Monocytes/100 leukocytes in Blood
577
4925
1.33
5.58
6.9
6.1
%
8.6
8.5
0.17
542
4548
(3013115) Eosinophils [#/volume] in Blood
630
5448
1.33
5.56
7.6
5.9
e9/l
0.2
0.2
2.98
549
4706
(3001604) Monocytes [#/volume] in Blood
608
5234
1.33
5.52
7.6
5.6
e9/l
0.6
0.6
0.43
525
4453
(3006315) Basophils [#/volume] in Blood
610
5254
1.33
5.52
7.6
5.6
e9/l
0.0
0.0
2.08
523
4473
(40760892) CBC W Ordered Manual Differential panel - Blood
283
2176
1.39
5.35
6.7
4.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
166
1155
1.51
5.34
1.9
2.7
%
2.0
1.9
0.65
159
1007
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
20
63
3.21
5.33
1.8
1.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
585
5028
1.32
5.29
6.8
6.0
%
26.5
28.3
2.62
546
4621
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
22
5.04
5.26
1.0
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
254
3272
0.72
5.22
3.3
3.1
mg/l
362.8
329.9
0.04
153
1821
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
136
1965
0.65
5.20
1.2
1.3
u/ml
10.6
14.3
0.39
55
721
(3020682) Albumin/Creatinine [Ratio] in Urine
271
3444
0.72
5.10
3.9
3.8
mg/mmol
18.9
6.2
4.18
167
1919
(3045424) Erythrocytes [Presence] in Urine
40
187
2.18
4.95
2.2
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
169
1203
1.47
4.86
1.6
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
169
1204
1.47
4.83
1.6
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
41
197
2.12
4.75
1.1
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
146
2045
0.67
4.75
1.2
1.3
iu/ml
61.6
40.3
0.27
49
678
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
85
519
1.69
4.74
9.1
8.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
24
91
2.67
4.67
1.7
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
46
237
1.98
4.45
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
269
3362
0.74
4.41
3.2
3.0
mmol/l
6.1
6.2
0.08
228
2781
(3000850) Epithelial cells [#/volume] in Urine
278
2195
1.35
4.37
2.5
2.5
e6/l
6.6
7.7
0.60
244
1911
(3019150) Specific gravity of Urine by Refractometry
290
2309
1.34
4.30
6.0
4.7
kg/l
1.0
1.0
0.70
31
351
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
64
1031
0.60
3.92
1.6
1.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
559
4909
1.26
3.81
6.7
5.8
%
2.4
2.7
3.56
522
4515
(3018010) Neutrophils/100 leukocytes in Blood
565
4972
1.26
3.77
6.7
5.8
%
57.7
57.0
0.48
529
4586
(3026726) Creatinine [Moles/volume] in Specimen
6
5
12.05
3.76
1.0
2.0
umol/l
50.2
365.8
—
6
5
(40761511) CBC panel - Blood by Automated count
1013
10570
0.72
3.75
26.9
13.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
460
3960
1.26
3.68
6.9
4.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
122
866
1.46
3.58
1.9
2.6
e9/l
67.3
72.4
0.53
67
644
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
623
0.52
3.57
1.7
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
324
2684
1.28
3.52
2.0
2.3
mg/l
2.9
3.1
0.55
280
2243
(3017354) Segmented neutrophils/100 leukocytes in Blood
22
95
2.34
3.35
2.6
2.9
%
57.2
58.5
0.08
17
53
(3030467) Casts [#/volume] in Urine by Automated count
344
2889
1.27
3.33
3.2
3.1
e6/l
0.7
0.5
0.58
263
2147
(36304419) Bacteria [Presence] in Urine
337
2824
1.27
3.32
3.1
3.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
119
856
1.43
3.26
8.0
2.5
ml/min/173m2
60.4
63.8
0.66
72
354
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
13
44
2.98
3.14
2.1
2.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
538
4776
1.23
3.12
6.6
5.9
%
0.7
0.7
0.92
507
4395
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
194
2433
0.76
3.11
1.2
1.3
u/ml
0.6
1.6
3.62
56
603
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
20
420
0.47
3.00
1.5
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
944
9887
0.78
2.90
30.9
13.8
ml/min/173m2
78.1
76.5
1.83
840
8105
(3014891) Appearance of Pleural fluid
6
9
6.69
2.87
1.7
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
162
2055
0.75
2.81
1.4
1.5
g/l
2.0
2.3
1.56
89
1146
(3000492) Spirometry study
58
879
0.64
2.78
1.3
1.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1051
10839
0.74
2.69
33.1
16.8
mmol/l
3.9
3.9
0.00
1035
10532
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
134
1028
1.34
2.54
2.3
2.2
u/l
34.0
39.5
0.61
120
871
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
102
749
1.40
2.54
6.9
3.0
pmol/l
4.3
4.4
0.84
96
644
(3019550) Sodium [Moles/volume] in Serum or Plasma
1051
10822
0.75
2.44
33.6
16.7
mmol/l
138.9
139.7
20.69
1034
10531
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
117
888
1.35
2.39
2.5
2.3
ug/l
3.7
5.9
1.73
104
758
(3022475) Manganese [Moles/volume] in Blood
5
8
6.27
2.37
1.4
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
22
3.65
2.36
1.1
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
53
348
1.55
2.33
1.1
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
215
1777
1.26
2.33
2.9
2.6
e6/l
1.8
1.6
0.16
117
958
(36660697) Celiac disease serology panel - Serum
62
891
0.68
2.32
1.1
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
11
41
2.70
2.28
1.3
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
409
3625
1.20
2.22
6.9
5.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
62
0.00
2.22
0.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
114
873
1.34
2.21
3.4
3.9
%
0.2
0.1
0.92
53
210
(3014765) Yersinia sp identified in Stool by Organism specific culture
53
353
1.52
2.20
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
8
199
0.40
2.17
1.1
1.6
nmol/l
1.3
0.8
—
8
153
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
197
1626
1.25
2.16
2.9
2.8
e6/l
4.2
4.1
0.06
102
812
(3017817) Protein [Mass] in Urine collected for unspecified duration
16
74
2.18
2.15
2.9
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
177
2146
0.79
2.13
1.9
1.7
nmol/l
1229.3
1196.5
0.18
137
1545
(3019832) Treponema pallidum Ab [Presence] in Serum
25
433
0.57
2.12
1.2
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
53
357
1.51
2.10
1.1
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
77
560
1.40
2.06
1.1
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
111
856
1.33
2.06
1.1
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
125
1.86
2.03
1.3
1.5
—
—
—
0
0
(4010399)
57
807
0.69
2.00
1.4
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
135
1677
0.78
2.00
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
35
547
0.63
1.99
1.3
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
240
2043
1.22
1.98
2.7
2.7
mosm/kgh2o
489.2
506.7
0.72
210
1728
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
449
4045
1.18
1.98
3.6
3.7
ng/l
26.4
54.2
0.83
351
2832
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
273
2355
1.21
1.97
1.3
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
37
234
1.60
1.95
5.0
3.9
mg/l
37.9
24.1
0.89
32
141
(3022145) Colonoscopy Study observation
97
1251
0.76
1.91
1.3
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
25
143
1.76
1.90
1.3
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
79
587
1.37
1.89
1.3
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
25
144
1.75
1.86
1.3
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
222
0.45
1.83
1.3
2.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
25
145
1.74
1.82
1.3
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
118
1472
0.78
1.81
1.3
1.3
titre
544.9
640.2
0.40
45
350
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
19
338
0.56
1.81
1.6
1.8
mg/l
4.6
3.9
0.13
14
249
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
246
0.48
1.78
1.3
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
13
258
0.50
1.76
3.0
3.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
119
1467
0.79
1.67
3.7
4.8
%
29.5
34.3
5.32
77
920
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
59
800
0.72
1.65
1.3
1.6
%
1.4
1.4
0.06
48
682
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
64
471
1.38
1.65
3.0
3.2
mmol/l
24.9
24.3
0.67
58
425
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
238
0.50
1.64
1.2
2.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
527
5685
0.87
1.63
2.4
2.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
91
710
1.30
1.60
10.0
2.9
e9/l
4.0
4.0
0.07
81
526
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
79
1020
0.76
1.60
2.7
3.2
ng/l
74.9
80.1
0.34
68
862
(3013139) Helicobacter pylori Ag [Presence] in Stool
60
806
0.73
1.59
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
35
231
1.53
1.58
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
35
231
1.53
1.58
1.2
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
143
0.42
1.52
1.3
1.9
%
87.2
89.8
—
6
143
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
125
0.40
1.50
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
127
1532
0.81
1.48
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
43
602
0.70
1.48
1.2
1.3
—
—
—
0
0
(1002224) Polysomnography panel
20
327
0.60
1.44
1.0
1.1
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
5
16
3.13
1.44
1.2
1.1
mmol/l
2.7
2.2
—
5
8
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
154
0.45
1.43
1.1
1.1
—
17.8
—
0
6
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
305
3394
0.86
1.42
2.2
2.1
u/l
142.0
187.6
1.10
286
3175
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
24
149
1.62
1.41
1.3
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
70
538
1.32
1.40
2.9
2.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
250
0.55
1.40
1.6
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
29
2.42
1.39
1.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
24
150
1.61
1.38
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
29
431
0.66
1.38
1.7
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
121
0.41
1.37
1.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
122
0.41
1.37
1.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
122
0.41
1.37
1.0
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
122
0.41
1.37
1.0
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
16
89
1.81
1.37
1.1
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
33
477
0.68
1.36
1.2
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
502
4658
1.13
1.36
15.4
9.4
e9/l
0.0
0.0
0.98
410
3772
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
0
40
0.00
1.32
0.0
1.7
—
15.4
—
0
30
(3036670) Protein [Mass/volume] in Synovial fluid
0
41
0.00
1.31
0.0
1.3
—
39.8
—
0
20
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
43
2.10
1.30
1.0
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
43
2.10
1.30
1.0
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
101
826
1.24
1.26
3.6
4.0
%
0.0
0.5
0.53
43
177
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
60
770
0.77
1.21
1.1
1.2
iu/ml
64.6
140.2
2.01
17
292
(3024522) Salmonella sp identified in Specimen by Organism specific culture
23
148
1.56
1.20
1.3
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
86
1.75
1.19
1.3
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
362
3317
1.13
1.17
2.9
3.0
ng/l
742.8
1189.4
3.36
328
2795
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
57
1.94
1.17
1.1
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
57
1.94
1.17
1.1
1.2
—
—
—
0
0
(44806420)
0
33
0.00
1.16
0.0
2.5
—
—
—
0
0
(4146454)
6
130
0.46
1.16
2.8
2.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
21
319
0.65
1.14
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
36
0.00
1.14
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
111
0.45
1.13
3.4
3.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
19
294
0.64
1.13
1.3
1.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
114
0.44
1.12
1.2
4.3
—
57.8
—
0
31
(3035947) Staphylolysin Ab [Units/volume] in Serum
8
40
2.01
1.12
1.3
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
45
337
1.35
1.11
2.7
3.6
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
21
2.39
1.09
1.4
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
40
534
0.74
1.08
1.2
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
32
2.19
1.08
2.4
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
32
2.19
1.08
2.4
2.6
—
—
—
0
0
(4094501)
19
290
0.65
1.07
1.2
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
659
6276
1.11
1.06
4.5
3.0
u/l
57.1
45.7
1.91
611
5721
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
463
0.73
1.05
2.5
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
463
0.73
1.05
2.5
2.4
g/l
7.4
7.6
0.29
26
356
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
33
451
0.72
1.04
2.0
1.7
—
—
—
0
0
(4034850)
45
341
1.33
1.04
9.2
9.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
462
0.73
1.04
2.5
2.4
g/l
3.5
3.7
0.51
26
342
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
437
0.72
1.01
2.6
2.5
g/l
3.2
3.2
0.13
26
351
(3032773) Endomysium IgG Ab [Titer] in Serum
15
91
1.66
1.00
1.1
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
116
989
1.19
1.00
1.2
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
133
0.52
0.99
1.1
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
51
647
0.78
0.98
1.5
1.2
u/ml
161.1
154.0
0.06
45
592
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
29
0.00
0.97
0.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
24
165
1.46
0.97
1.4
1.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
24
340
0.70
0.95
1.3
2.3
g/l
0.0
0.0
0.00
24
314
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
131
1136
1.17
0.94
3.3
3.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
158
1.46
0.94
1.2
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
43
331
1.31
0.92
1.2
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
110
1278
0.85
0.92
1.7
2.0
ug/g
171.6
134.9
0.30
85
991
(3004716) Salmonella sp identified in Stool by Organism specific culture
65
528
1.24
0.92
1.2
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
24
337
0.71
0.91
1.3
2.3
g/l
0.0
0.0
0.00
24
313
(3001019) Free T4 and TSH panel - Serum or Plasma
35
461
0.75
0.90
1.7
1.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
102
0.49
0.89
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
103
0.48
0.89
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
205
0.63
0.88
1.4
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
378
3527
1.11
0.87
2.6
3.7
ph
7.4
7.4
0.20
49
654
(3001122) Ferritin [Mass/volume] in Serum or Plasma
413
4396
0.91
0.87
2.5
2.8
ug/l
232.3
103.9
9.03
392
3995
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
39
502
0.77
0.86
1.8
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
66
795
0.82
0.83
2.2
2.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
253
2319
1.12
0.82
2.9
2.9
mmol/l
2.5
2.5
6.29
230
2054
(3003327) Ova and parasites identified in Stool by Light microscopy
24
328
0.73
0.80
1.6
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
33
1.82
0.79
1.0
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
96
0.52
0.78
1.2
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
27
0.00
0.77
0.0
1.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
97
838
1.17
0.76
3.5
3.7
%
0.8
0.6
0.33
32
159
(3013293) Extractable nuclear Ab [Presence] in Serum
5
24
2.09
0.74
1.2
1.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
24
2.09
0.74
1.4
2.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
17
116
1.47
0.74
1.2
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
818
8406
0.91
0.74
38.0
18.0
%
14.7
13.8
41.07
807
8196
(3021788) Differential panel - Synovial fluid
13
196
0.66
0.74
1.4
1.7
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
27
356
0.75
0.73
2.5
2.3
g/l
0.0
0.0
0.50
27
329
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
195
0.66
0.72
1.1
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
60
1.67
0.72
1.0
1.0
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
5
27
1.86
0.68
1.0
1.4
%
31.0
26.2
—
5
22
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
34
429
0.79
0.67
1.3
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
40
495
0.80
0.67
1.2
1.1
titre
—
268.1
—
0
13
(3010726) Horse dander IgE Ab [Units/volume] in Serum
5
91
0.55
0.67
1.0
1.0
—
0.4
—
0
20
(3022313) Gas panel - Capillary blood
51
421
1.22
0.67
5.3
3.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
65
550
1.19
0.66
4.6
3.4
mmol/l
1.9
2.1
0.18
54
425
(3041096) Erythrocytes [Presence] in Urine by Automated
289
2702
1.09
0.64
6.3
3.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
127
0.63
0.64
1.4
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
129
0.62
0.64
1.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
20
269
0.74
0.63
1.5
1.8
e6/l
11056.5
12409.9
0.10
15
190
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
131
0.61
0.63
1.3
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
67
572
1.18
0.63
4.5
3.6
ph
7.4
7.4
—
10
81
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
41
333
1.24
0.63
1.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
17
121
1.41
0.62
1.1
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
103
0.58
0.62
1.0
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
29
368
0.78
0.62
1.2
1.4
ug/g
277.2
293.9
0.21
16
210
(4198724)
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
20
0.00
0.60
0.0
1.2
—
1.6
—
0
20
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
15
208
0.72
0.58
2.3
2.4
ug/min
42.5
53.9
—
7
125
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
99
879
1.14
0.57
9.6
4.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
88
0.57
0.56
1.4
1.4
nmol/l
2.0
1.5
—
5
74
(3044242) Glucose [Moles/volume] in Arterial blood
8
55
1.46
0.56
1.7
2.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
89
0.56
0.56
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
19
250
0.76
0.54
1.5
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
255
2397
1.08
0.51
1.6
1.7
pmol/l
35185628.6
26597311.0
0.09
216
1910
(3025130) Human papilloma virus identified in Specimen
18
136
1.33
0.49
1.8
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
136
1.33
0.49
1.3
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
11
154
0.71
0.47
1.5
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
28
227
1.24
0.47
1.3
1.4
mmol/l
61.7
58.2
0.17
21
175
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
21
265
0.79
0.46
1.3
1.4
—
28.8
—
0
7
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
82
0.61
0.46
1.2
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
818
8340
0.94
0.45
43.7
19.4
g/l
328.3
330.2
9.10
812
8271
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
84
0.59
0.45
1.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
29
352
0.82
0.45
1.8
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
121
0.66
0.45
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
140
0.71
0.43
1.1
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
68
764
0.88
0.43
2.7
3.0
g/l
9.8
10.3
0.31
62
689
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
222
2092
1.08
0.43
3.2
3.7
ng/l
70.5
261.0
3.10
173
1649
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
20
158
1.27
0.42
1.8
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
70
1.43
0.41
2.7
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
15
0.00
0.41
0.0
3.1
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.5
—
2.1
—
0
10
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
15
0.00
0.41
0.0
3.1
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
16
0.00
0.41
0.0
1.4
—
4.7
—
0
8
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
16
0.00
0.41
0.0
5.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
17
216
0.78
0.40
1.9
2.5
%
13.7
15.9
2.24
12
103
(3023511) Choriogonadotropin [Units/volume] in Urine
12
88
1.37
0.40
1.6
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
80.2
—
0
19
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1041
10303
1.08
0.39
23.3
14.4
mg/l
36.5
21.8
30.19
979
8098
(4306422)
17
133
1.28
0.38
1.2
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
23
280
0.82
0.38
1.1
1.1
u/ml
3.4
7.6
—
6
30
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
29
243
1.20
0.38
1.9
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
68
1.33
0.37
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
112
0.71
0.37
1.3
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
18
224
0.80
0.37
2.4
3.8
mmol/l
2.7
3.0
—
10
167
(3045142) Bone marrow Pathology biopsy report
16
125
1.28
0.37
1.3
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
70
1.29
0.36
1.2
1.5
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
5
78
0.64
0.35
1.6
1.4
—
370.0
—
0
9
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
42
1.43
0.35
1.0
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
18
144
1.25
0.35
1.2
1.2
u/ml
4.0
5.9
—
7
56
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
123
0.73
0.35
1.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
123
0.73
0.35
1.4
2.0
pg
33.4
31.8
—
9
123
(3044927) Protein electrophoresis panel - Urine
9
125
0.72
0.35
1.0
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
19
232
0.82
0.34
5.3
3.1
mg/l
1.4
1.5
0.71
19
212
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
18
145
1.25
0.34
1.8
2.2
mg/l
17.3
24.9
—
8
34
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
155
0.77
0.33
1.1
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
86
0.70
0.33
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
89
0.67
0.33
2.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
113
1212
0.93
0.32
3.4
4.1
—
—
—
0
0
(4268621)
12
92
1.31
0.32
2.5
2.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
97
0.72
0.31
1.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
53
1.32
0.31
1.0
1.2
—
—
—
0
0
(3010421) pH of Blood
23
272
0.84
0.30
2.8
3.5
ph
7.4
7.4
0.66
17
222
(44806118)
13
102
1.28
0.30
1.5
1.4
—
—
—
0
0
(44790047)
13
102
1.28
0.30
1.5
1.4
—
—
—
0
0
(44790048)
13
102
1.28
0.30
1.5
1.4
—
—
—
0
0
(44790049)
13
102
1.28
0.30
1.5
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
55
1.27
0.30
1.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
25
213
1.18
0.29
3.8
3.6
%
60.0
58.0
0.35
25
213
(21494890) Protein electrophoresis panel - 24 hour Urine
8
109
0.73
0.29
1.0
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
56
617
0.90
0.28
1.8
1.8
g/l
1.3
1.4
0.08
48
549
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
12
94
1.28
0.28
1.1
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
63
1.27
0.27
1.0
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
140
1.22
0.27
1.1
1.1
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
8
66
1.21
0.26
1.0
1.6
%
77.1
73.0
—
8
60
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
45
405
1.12
0.26
1.2
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
71
0.70
0.26
1.2
2.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
5
72
0.69
0.26
1.6
1.2
u/l
23.6
14.9
—
5
62
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
26
225
1.16
0.26
1.3
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
73
0.68
0.26
1.4
1.8
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
5
74
0.67
0.26
1.6
1.2
u/l
91.8
70.7
—
5
65
(44813793)
5
75
0.67
0.26
1.2
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
75
1.20
0.25
1.3
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
84
0.71
0.24
1.5
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
16
190
0.84
0.23
1.3
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
38
1.32
0.23
1.6
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
136
0.81
0.23
1.5
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
42
1.19
0.21
1.2
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
1.0
—
0
6
(3019174) dRVVT (LA screen)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(4212803)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
0.0
—
0
5
(3044009) aPTT.lupus sensitive (LA screen)
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
19.3
—
0
10
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
10
0.00
0.21
0.0
20.8
—
5.3
—
0
10
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
8
105
0.76
0.21
1.4
1.0
g/l
1.7
1.5
—
8
91
(3017569) Oxygen content in Arterial blood
5
43
1.16
0.21
1.4
2.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
26
293
0.88
0.21
1.2
1.5
iu/ml
0.0
0.1
0.71
11
55
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
13
0.00
0.21
0.0
5.7
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
38.0
—
0
14
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
193
1.14
0.19
1.5
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
13
154
0.84
0.19
1.1
1.0
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
10
81
1.24
0.18
1.0
1.1
mmol/l
32.2
32.6
—
10
72
(3014271) Vancomycin [Susceptibility]
6
53
1.13
0.18
2.3
3.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
128
1.17
0.18
1.3
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
254
2611
0.97
0.18
2.5
2.4
umol/l
6887.3
5930.0
0.11
226
2202
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
121
0.82
0.18
1.2
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
163
0.86
0.17
1.1
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
5
67
0.75
0.17
1.4
1.3
—
11.6
—
0
15
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
5
68
0.73
0.17
2.0
1.3
u/l
4.2
5.1
—
5
58
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
17
148
1.15
0.17
1.2
1.2
u/ml
8.4
3.2
—
7
38
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
69
0.72
0.17
2.4
2.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
70
0.71
0.16
1.2
1.5
g/l
1.0
1.0
—
5
70
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29
319
0.91
0.16
1.3
1.3
u/ml
10.9
10.0
—
6
66
(46235355) HIV 1 and 2 tests - Meaningful Use set
104
1086
0.95
0.16
1.2
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
120
1248
0.96
0.15
1.3
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
24
265
0.90
0.15
1.1
1.2
—
89.3
—
0
14
(3051611) Lipemic interference index of Serum or Plasma
11
129
0.85
0.14
2.9
3.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
25
275
0.91
0.14
2.6
3.4
nmol/l
0.8
0.8
0.08
19
212
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
86
0.81
0.14
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
86
0.81
0.14
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
86
0.81
0.14
1.3
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
237
1.10
0.14
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
58
612
0.95
0.13
6.8
3.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
16
180
0.89
0.13
1.1
1.3
nmol/l
0.7
0.7
0.00
16
172
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
9
106
0.85
0.13
1.4
1.1
—
68.3
—
0
7
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
107
0.84
0.13
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
58
550
1.06
0.13
1.1
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
30
324
0.92
0.12
1.4
1.6
—
232.9
—
0
17
(3034770) Mitochondria Ab [Titer] in Serum
29
268
1.08
0.12
1.1
1.2
—
1075.4
—
0
13
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
23
251
0.91
0.12
1.0
1.3
mg/l
481.2
513.1
0.19
23
239
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
20
220
0.91
0.12
1.1
1.5
e6/l
938.5
594.6
0.18
15
178
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
20
220
0.91
0.12
1.0
1.4
e6/l
4.1
11.7
0.89
14
164
(3044889) 12 lead EKG panel
749
7540
0.98
0.10
4.2
3.9
—
—
—
0
0
(4027681)
5
45
1.11
0.10
1.2
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
45
1.11
0.10
1.0
1.4
nmol/l
133.0
139.1
—
5
45
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
48
1.04
0.09
1.0
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
155
0.90
0.09
1.1
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
41
431
0.95
0.09
1.6
2.0
u/l
39.0
40.5
0.20
32
376
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
55
1.09
0.09
1.3
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
136
1.10
0.08
1.1
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
65
0.77
0.08
1.2
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
47
450
1.05
0.08
1.6
1.9
g/l
1.9
1.6
0.75
41
393
(3051651) Icteric interference index of Serum or Plasma
7
65
1.08
0.08
3.9
3.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
127
1.10
0.08
4.0
2.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
27
254
1.06
0.08
1.9
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
74
1.08
0.07
1.0
1.0
—
—
—
0
0
(3013512) EKG study
337
3333
1.02
0.07
4.7
3.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
137
1.10
0.07
2.3
2.5
—
—
—
0
0
(4024509)
15
137
1.10
0.07
1.3
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
81
0.86
0.07
1.0
1.6
%
11.4
10.8
—
7
81
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
85
0.82
0.07
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
85
0.82
0.07
1.3
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
85
0.82
0.07
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
85
0.82
0.07
1.3
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
84
1.07
0.07
1.6
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
84
1.07
0.07
1.6
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
84
1.07
0.07
1.6
1.3
—
—
—
0
0
(4062490)
8
90
0.89
0.06
1.4
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
30
285
1.05
0.06
5.2
4.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
148
1.08
0.06
1.2
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
266
2689
0.99
0.06
1.7
1.5
nmol/l
19.6
22.4
2.62
246
2227
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
182
0.93
0.05
1.2
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
14
130
1.08
0.04
1.1
1.4
—
23.8
—
0
6
(3049717) Cytology report of Urine Cyto stain
28
292
0.96
0.04
2.5
2.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
17
179
0.95
0.03
1.1
1.3
nmol/l
—
0.6
—
0
7
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
32
310
1.03
0.03
2.1
1.8
iu/l
5.2
4.6
0.20
12
92
(3023419) Bacteria identified in Sputum by Culture
12
128
0.94
0.02
1.9
2.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
29
299
0.97
0.02
4.0
2.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
218
0.96
0.02
1.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
103
1.07
0.02
1.8
2.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
10
107
0.93
0.02
1.4
1.2
—
88.8
—
0
5
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
15
143
1.05
0.01
1.1
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
19
197
0.96
0.01
1.0
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
65
656
0.99
0.00
2.3
2.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
96
1.04
0.00
1.5
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
22
224
0.98
0.00
1.3
1.3
miu/ml
304.6
233.7
—
8
94
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
234
0.98
0.00
1.3
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
108
1.02
0.00
1.1
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
20
202
0.99
0.00
2.0
3.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
17
171
0.99
0.00
2.2
2.9
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
10
103
0.97
0.00
1.3
1.1
%
103.5
96.6
—
10
98
(3019230) Fractional oxyhemoglobin in Venous blood
17
167
1.02
0.00
1.1
1.7
%
64.8
61.1
0.27
17
167
(3024928) Oxygen saturation in Venous blood
22
217
1.01
0.00
1.0
2.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
76
765
0.99
0.00
3.8
3.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
18
175
1.03
0.00
1.4
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
135
1.04
0.00
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
215
0.98
0.00
1.4
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
105
0.95
0.00
1.5
1.3
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
107.0
—
0
6
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.0
—
19.9
—
0
6
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
6.5
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
7
0.00
0.00
0.0
1.4
—
17.6
—
0
7
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
21.4
—
0
9
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
57
0.88
0.00
1.2
1.6
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
8.2
—
0
9
(3024263) Appearance of Synovial fluid
6
60
1.00
0.00
1.5
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
95
0.95
0.00
1.0
1.7
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
37.5
—
0
9
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
55
0.91
0.00
1.2
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
57
0.88
0.00
1.2
1.6
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
55
0.91
0.00
1.2
1.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
8
86
0.93
0.00
1.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
6.8
—
0
9
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
5
57
0.88
0.00
1.0
1.1
mg/l
415.8
238.2
—
5
50
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
55
0.91
0.00
1.2
1.2
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
4.8
—
0
8
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
55
0.91
0.00
1.2
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
54
0.93
0.00
1.0
2.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_OVARY_SEROUS – Serous carcinoma of ovary

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).